1.
Clin Lung Cancer
; 21(5): e474-e477, 2020 09.
Artículo
en Inglés
| MEDLINE
| ID: mdl-32299770
Asunto(s)
Carcinoma de Pulmón de Células no Pequeñas/tratamiento farmacológico , Encefalitis/patología , Inhibidores de Puntos de Control Inmunológico/efectos adversos , Neoplasias Pulmonares/tratamiento farmacológico , Carcinoma de Pulmón de Células no Pequeñas/patología , Encefalitis/inducido químicamente , Femenino , Humanos , Neoplasias Pulmonares/patología , Masculino , Persona de Mediana Edad , Pronóstico
2.
BMJ Case Rep
; 20182018 Jan 12.
Artículo
en Inglés
| MEDLINE
| ID: mdl-29330272
RESUMEN
Splenic rupture is an infrequent and underdiagnosed side effect of granylocyte colony-stimulating factor (G-CSF). We report the case of a 54-year-old woman with brain and bone metastasis in a lung adenocarcinoma who was admitted for faintness 28 days after a G-CSF injection. Abdominal CT scan confirmed the diagnosis of splenic rupture. A conservative treatment was chosen using a peritoneal cleansing during laparoscopic surgery. Clinicians should be aware of this rare toxicity as it could be severe, but easily reversible using appropriate surgical treatment. Even if prognosis remains poor for patients with lung cancer, invasive procedures could be considered in this rapidly evolving setting, especially in case of reversible adverse event.